Galenika's quality – portfolio growth, customer orientation, and further globalization of business
01/23/2024 • Customer news
With a strategic partnership with its sister company from Brazil - EMS, Galenika has successfully implemented technology transfer for six products from the newer generation of generic drugs since the beginning of 2023 and has started preparations for three more. As Carlos Puglia, executive director for sales and marketing, told in an interview for BIZLife, the Galenika company is strategically committed to constantly expanding its portfolio with cutting-edge products for the benefit of consumers, and the current portfolio includes 280 generic prescription drugs, OTC drugs, nutritional supplements, cosmetic products, medical devices, and items of general use.
You can read the interview here.